510 related articles for article (PubMed ID: 29611051)
1. IgA Vasculitis: Genetics and Clinical and Therapeutic Management.
González-Gay MA; López-Mejías R; Pina T; Blanco R; Castañeda S
Curr Rheumatol Rep; 2018 Apr; 20(5):24. PubMed ID: 29611051
[TBL] [Abstract][Full Text] [Related]
2. Brief Report: Rituximab for the Treatment of Adult-Onset IgA Vasculitis (Henoch-Schönlein).
Maritati F; Fenoglio R; Pillebout E; Emmi G; Urban ML; Rocco R; Nicastro M; Incerti M; Goldoni M; Trivioli G; Silvestri E; Mohammad AJ; Jayne D; Eriksson P; Segelmark M; Novikov P; Harris H; Roccatello D; Vaglio A
Arthritis Rheumatol; 2018 Jan; 70(1):109-114. PubMed ID: 28973844
[TBL] [Abstract][Full Text] [Related]
3. Genetics of immunoglobulin-A vasculitis (Henoch-Schönlein purpura): An updated review.
López-Mejías R; Castañeda S; Genre F; Remuzgo-Martínez S; Carmona FD; Llorca J; Blanco R; Martín J; González-Gay MA
Autoimmun Rev; 2018 Mar; 17(3):301-315. PubMed ID: 29353097
[TBL] [Abstract][Full Text] [Related]
4. Case of Gut Necrosis in Adult-Onset Immunoglobulin A Vasculitis (Henoch-Schönlein Purpura).
Weissman AS; Patel VS; Mushfiq O
J Investig Med High Impact Case Rep; 2020; 8():2324709620925565. PubMed ID: 32434396
[TBL] [Abstract][Full Text] [Related]
5. Adult-onset IgA vasculitis (Henoch-Schönlein): Update on therapy.
Maritati F; Canzian A; Fenaroli P; Vaglio A
Presse Med; 2020 Oct; 49(3):104035. PubMed ID: 32645417
[TBL] [Abstract][Full Text] [Related]
6. IgA Vasculitis in Adults: a Rare yet Challenging Disease.
Yaseen K; Herlitz LC; Villa-Forte A
Curr Rheumatol Rep; 2021 Jul; 23(7):50. PubMed ID: 34196893
[TBL] [Abstract][Full Text] [Related]
7. Comparing immunoglobulin A vasculitis (Henoch-Schönlein purpura) in children and adults: a single-centre study from Turkey.
Batu ED; Sarı A; Erden A; Sönmez HE; Armağan B; Kalyoncu U; Karadağ Ö; Bilginer Y; Akdoğan A; Kiraz S; Özen S
Scand J Rheumatol; 2018 Nov; 47(6):481-486. PubMed ID: 29912602
[TBL] [Abstract][Full Text] [Related]
8. European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative.
Ozen S; Marks SD; Brogan P; Groot N; de Graeff N; Avcin T; Bader-Meunier B; Dolezalova P; Feldman BM; Kone-Paut I; Lahdenne P; McCann L; Pilkington C; Ravelli A; van Royen A; Uziel Y; Vastert B; Wulffraat N; Kamphuis S; Beresford MW
Rheumatology (Oxford); 2019 Sep; 58(9):1607-1616. PubMed ID: 30879080
[TBL] [Abstract][Full Text] [Related]
9. New insights in the pathogenesis of immunoglobulin A vasculitis (Henoch-Schönlein purpura).
Heineke MH; Ballering AV; Jamin A; Ben Mkaddem S; Monteiro RC; Van Egmond M
Autoimmun Rev; 2017 Dec; 16(12):1246-1253. PubMed ID: 29037908
[TBL] [Abstract][Full Text] [Related]
10. Association of kidney biopsy findings with short- and medium-term outcomes in children with moderate-to-severe IgA vasculitis nephritis.
Clavé S; Sordet M; Tsimaratos M; Decramer S; Fila M; Guigonis V; Faudeux C; Daniel L; Torrents J; Boucekine M; Harambat J; Rousset-Rouvière C
Eur J Pediatr; 2021 Oct; 180(10):3209-3218. PubMed ID: 33934234
[TBL] [Abstract][Full Text] [Related]
11. Multisystemic manifestations of IgA vasculitis.
Du L; Wang P; Liu C; Li S; Yue S; Yang Y
Clin Rheumatol; 2021 Jan; 40(1):43-52. PubMed ID: 32557258
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular, thromboembolic and renal outcomes in IgA vasculitis (Henoch-Schönlein purpura): a retrospective cohort study using routinely collected primary care data.
Tracy A; Subramanian A; Adderley NJ; Cockwell P; Ferro C; Ball S; Harper L; Nirantharakumar K
Ann Rheum Dis; 2019 Feb; 78(2):261-269. PubMed ID: 30487151
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and Management of IgA Vasculitis (Henoch-Schönlein) in Adults: Data From 260 Patients Included in a French Multicenter Retrospective Survey.
Audemard-Verger A; Terrier B; Dechartres A; Chanal J; Amoura Z; Le Gouellec N; Cacoub P; Jourde-Chiche N; Urbanski G; Augusto JF; Moulis G; Raffray L; Deroux A; Hummel A; Lioger B; Catroux M; Faguer S; Goutte J; Martis N; Maurier F; Rivière E; Sanges S; Baldolli A; Costedoat-Chalumeau N; Roriz M; Puéchal X; André M; Lavigne C; Bienvenu B; Mekinian A; Zagdoun E; Girard C; Bérezné A; Guillevin L; Thervet E; Pillebout E;
Arthritis Rheumatol; 2017 Sep; 69(9):1862-1870. PubMed ID: 28605168
[TBL] [Abstract][Full Text] [Related]
14. Value of biomarkers for predicting immunoglobulin A vasculitis nephritis outcome in an adult prospective cohort.
Berthelot L; Jamin A; Viglietti D; Chemouny JM; Ayari H; Pierre M; Housset P; Sauvaget V; Hurtado-Nedelec M; Vrtovsnik F; Daugas E; ; Monteiro RC; Pillebout E;
Nephrol Dial Transplant; 2018 Sep; 33(9):1579-1590. PubMed ID: 29126311
[TBL] [Abstract][Full Text] [Related]
15. Rituximab treatment for IgA vasculitis: A systematic review.
Hernández-Rodríguez J; Carbonell C; Mirón-Canelo JA; Diez-Ruiz S; Marcos M; Chamorro AJ
Autoimmun Rev; 2020 Apr; 19(4):102490. PubMed ID: 32062030
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of mizoribine and prednisolone combination therapy in adult patients with IgA vasculitis.
Mima A
Rheumatol Int; 2017 Aug; 37(8):1387-1393. PubMed ID: 28255645
[TBL] [Abstract][Full Text] [Related]
17. Rituximab in severe immunoglobulin-A vasculitis (Henoch-Schönlein) with aggressive nephritis.
Fenoglio R; Sciascia S; Naretto C; De Simone E; Del Vecchio G; Ferro M; Quattrocchio G; Roccatello D
Clin Exp Rheumatol; 2020; 38 Suppl 124(2):195-200. PubMed ID: 32441647
[TBL] [Abstract][Full Text] [Related]
18. Predictive biomarkers of IgA vasculitis with nephritis by metabolomic analysis.
Demir S; Kaplan O; Celebier M; Sag E; Bilginer Y; Lay I; Ozen S
Semin Arthritis Rheum; 2020 Dec; 50(6):1238-1244. PubMed ID: 33065418
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers of IgA vasculitis nephritis in children.
Pillebout E; Jamin A; Ayari H; Housset P; Pierre M; Sauvaget V; Viglietti D; Deschenes G; Monteiro RC; Berthelot L;
PLoS One; 2017; 12(11):e0188718. PubMed ID: 29190714
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
